Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  INC Research Holdings Inc    

INC RESEARCH HOLDINGS INC
My previous session
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of INC Research Holdings, Inc. (INCR)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 06:43pm CEST

NEW YORK, Nov. 10, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of INC Research Holdings, Inc. ("INC Research" or the "Company") (NASDAQ: INCR). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/incr.

The investigation concerns whether INC Research and certain of its officers and/or directors have violated Sections federal securities laws.

On August 1, 2017, INC Research and inVentiv Health, Inc. ("inVentiv Health") announced the completion of a merger between the two companies. On November 9, 2017, INC Research reported its first financial results after combining with inVentiv Health. The Company's combined results were negatively impacted by merger-related expenses, an impairment charge and increased amortization expenses. Following this news, INC Research stock dropped $16.35 per share, or 28.43%, to close at $41.15 on November 9, 2017.

If you are aware of any facts relating to this investigation, or purchased shares of INC Research, you can assist this investigation by visiting the firm's site: www.bgandg.com/incr. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-inc-research-holdings-inc-incr-300553934.html

SOURCE Bronstein, Gewirtz & Grossman, LLC


© PRNewswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INC RESEARCH HOLDINGS INC
08/24SYNEOS HEALTH : Greg Rush joins Parexel as Executive VP & CFO
AQ
08/21SYNEOS HEALTH : Acquires Kinapse to Further Enhance End-to-End Capabilities
AQ
08/21SYNEOS HEALTH : acquires consulting firm to boost regulatory, safety, pharmacovi..
AQ
08/21SYNEOS HEALTH : acquires advisory & operational solutions provider Kinapse
AQ
08/20SYNEOS HEALTH, INC. : Regulation FD Disclosure, Financial Statements and Exhibit..
AQ
08/20Syneos Health™ Acquires Kinapse to Further Enhance End-to-End Capabilit..
GL
08/17Syneos Health to Present at the 2018 Baird Global Healthcare Conference
GL
08/17SYNEOS HEALTH : PAREXEL Announces Appointment of Two Key Executives
AQ
08/08SYNEOS HEALTH, INC. : Entry into a Material Definitive Agreement, Financial Stat..
AQ
08/08SYNEOS HEALTH : Announces Pricing of Secondary Offering of Common Stock
AQ
More news
News from SeekingAlpha
01/03INC Research CFO exiting post at April's end 
2017INC Research Holdings 2017 Q3 - Results - Earnings Call Slides 
2017INC Research's (INCR) CEO Alistair MacDonald on Q3 2017 Results - Earnings Ca.. 
2017Midday Gainers / Losers 
2017INC Research misses by $0.08, misses on revenue